POLYPOIDAL CHOROIDAL VASCULOPATHY
Clinical trials for POLYPOIDAL CHOROIDAL VASCULOPATHY explained in plain language.
Never miss a new study
Get alerted when new POLYPOIDAL CHOROIDAL VASCULOPATHY trials appear
Sign up with your email to follow new studies for POLYPOIDAL CHOROIDAL VASCULOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New eye drug trial offers hope for rare vision condition
Disease control Recruiting nowThis study tests a drug called faricimab, given as an eye injection, for Caucasian patients with polypoidal choroidal vasculopathy (PCV), a condition that causes vision loss. About 120 participants will receive the treatment and be monitored for up to 48 weeks to see if their eye…
Matched conditions: POLYPOIDAL CHOROIDAL VASCULOPATHY
Phase: PHASE4 • Sponsor: Association for Innovation and Biomedical Research on Light and Image • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New eye drug regimen could mean fewer shots for PCV patients
Disease control Recruiting nowThis phase 3 trial is testing a personalized treatment plan using high-dose aflibercept (8 mg) for people with polypoidal choroidal vasculopathy (PCV), a condition that causes vision loss. The goal is to see if adjusting the injection schedule based on each person's response can …
Matched conditions: POLYPOIDAL CHOROIDAL VASCULOPATHY
Phase: PHASE3 • Sponsor: Yeungnam University College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC